Saint Thomas Heart First in State to Offer New Alternative to Open-Heart Surgery
Saint Thomas Heart is proud to announce they are the first center in Tenn. to offer the MitraClip as part of a national clinical trial for patients with congestive heart failure (CHF) and mitral regurgitation (MR), the most common type of heart valve insufficiency in the United States.
The MitraClip is a small metal clip that helps patients with MR, a condition in which the heart’s mitral valve leaflets do not close tightly, causing blood to leak into the heart’s left atrium. The condition can lead to advanced heart failure and affects approximately 4 million people in the United States.
This new treatment expands the options for selected patients with MR, especially those who are not candidates for invasive open-heart surgery. The procedure allows doctors to use catheter-based technology to repair the mitral valve via a groin puncture without requiring patients to undergo cardiopulmonary bypass or the need for traditional chest incisions.
The MitraClip procedure shortens recovery time and ultimately improves quality of life for those experiencing life-altering symptoms like fatigue and shortness of breath.
The new MitraClip trial is a great complement to the ongoing transcatheter aortic valve replacement (TAVR) program, which helps patients with severe aortic stenosis, narrowing of the opening of the aortic valve in the heart. The MitraClip is the only valve replacement option for patients with severe aortic stenosis who are not well enough to undergo traditional open-heart surgery. Without surgery, 50 percent of symptomatic patients with severe aortic stenosis will die within an average of two years if untreated.
To learn more about the MitraClip trial and treatment, visit http://youtu.be/mC-hSxksR3k
For more information about the MitraClip procedure, contact the Saint Thomas Heart Valve Center at 855.789.2593.